A system combining a tiny sensor with oral chemotherapy drugs aims to provide physicians with closer monitoring of cancer patients’ treatments and conditions. . . . → Read More: Sensor-Pill System Designed for Cancer Drugs
|
|||||
|
|
A start-up enterprise begun by students at Purdue University developed an iPhone app that detects mild brain injuries by measuring responses of eyes to light. . . . → Read More: Univ. Spin-Off Creates Concussion Detection App 
Wearers of Fitbit activity tracking devices now have the option of sharing their data with a large-scale precision medicine project run by National Institutes of Health. . . . → Read More: Fitbit Devices Providing Precision Medicine Data 
An alliance of research organizations is designing ways to cut the time needed to develop, test, and manufacture new vaccines to as little as 6 months. . . . → Read More: Consortium to Speed Vaccine Production 
Regulatory review of a drug to prevent allergic reactions to peanuts appears to be delayed by the shutdown of some U.S. government operations. . . . → Read More: Shutdown Delays FDA Peanut Allergy Drug Review 
Customized implants, produced on a 3-D printer and seeded with stem cells, are shown in tests with lab animals to restore nerve signals and functioning after a spinal cord injury. . . . → Read More: 3-D Printed Implants Treat Spinal Cord Injury 
Medical researchers are developing a treatment for a frequent side-effect of Parkinson’s disease drugs using a corrective RNA molecule to reverse the condition. . . . → Read More: RNA Therapy Studied for Parkinson’s Side Effects 
A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial. . . . → Read More: Spin-Off Gains Seed Funds for Non-Opioid Pain Drug 
A computational biology lab designed a synthetic protein that works like natural cancer-fighting proteins, but in lab mice kills cancer cells with few adverse effects. . . . → Read More: Cancer-Fighting Protein Designed to Cut Adverse Effects 
A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London. . . . → Read More: Start-up Funds Univ. Medical Cannabis Research |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
